Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Bortezomib administration is a risk factor associated with the development of tumor lysis syndrome in male patients with multiple myeloma: a retrospective study.

  • Authors : Kondo M; Department of Pharmacy, Nagoya City University Hospital, 1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, 467-8602, Japan.; Hotta Y

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*adverse effects ; Bortezomib/Bortezomib/Bortezomib/*adverse effects ; Multiple Myeloma/Multiple Myeloma/Multiple Myeloma/*drug therapy

  • Source: BMC cancer [BMC Cancer] 2020 Nov 17; Vol. 20 (1), pp. 1117. Date of Electronic Publication: 2020 Nov 17.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

×
  • 1-10 ل  89 نتائج ل ""Lysis""